Many diverse types of tumors express elevated levels of the CD137 ligand, CD137L, accompanied by increased expression of CD137 on immune cells within the tumor environment, while expression of either is negligible on healthy cells (115, 118–120). The gene discussed is TNFSF9; the disease is neoplasm.